非创伤性股骨头坏死患者血清颗粒蛋白前体表达及临床意义

doi:10.11958/20220985

天津医药 ›› 2022, Vol. 50 ›› Issue (12): 1302-1305.doi: 10.11958/20220985

非创伤性股骨头坏死患者血清颗粒蛋白前体表达及临床意义

纪沣轩¹^,²(), 李国鹏³, 毕彤⁴, 张维民⁵, 贾庆运⁶, 韦标方²^,^△()

1 锦州医科大学（邮编121000）
2 临沂市人民医院股骨头专科
3 潍坊医学院
4 深圳市第四人民医院内分泌科
5 滨州医学院
6 临沂市人民医院创伤二科

收稿日期:2022-06-24 修回日期:2022-08-02 出版日期:2022-12-15 发布日期:2022-12-30
通讯作者: 韦标方 E-mail:823464364@qq.com;weibiaofang@163.com
作者简介:纪沣轩（1994），男，硕士在读，主要从事股骨头坏死临床方面研究。E-mail：823464364@qq.com
基金资助:
山东省自然科学基金项目(ZR2021QH230);山东省科技攻关计划项目(2014GSF119022);临沂市科技发展计划(201717097)

Clinical significance of serum expression of progranulin in non-traumatic osteonecrosis of femoral head

JI Fengxuan¹^,²(), LI Guopeng³, BI Tong⁴, ZHANG Weimin⁵, JIA Qingyun⁶, WEI Biaofang²^,^△()

1 Jinzhou Medical University, Jinzhou 121000, China
2 Department of Femoral Head, Linyi People's Hospital
3 Weifang Medical College
4 Department of Medicine and Endocrinology of the Fourth People's Government of Shenzhen
5 Binzhou Medical College
6 Second Department of Trauma, Linyi People's Hospital

Received:2022-06-24 Revised:2022-08-02 Published:2022-12-15 Online:2022-12-30
Contact: WEI Biaofang E-mail:823464364@qq.com;weibiaofang@163.com

纪沣轩, 李国鹏, 毕彤, 张维民, 贾庆运, 韦标方. 非创伤性股骨头坏死患者血清颗粒蛋白前体表达及临床意义[J]. 天津医药, 2022, 50(12): 1302-1305.

JI Fengxuan, LI Guopeng, BI Tong, ZHANG Weimin, JIA Qingyun, WEI Biaofang. Clinical significance of serum expression of progranulin in non-traumatic osteonecrosis of femoral head[J]. Tianjin Medical Journal, 2022, 50(12): 1302-1305.

摘要/Abstract

摘要：

目的探讨血清颗粒蛋白前体（PGRN）测定对非创伤性股骨头坏死（NONFH）的临床诊断价值。方法选取75例NONFH患者为NONFH组，性别和年龄匹配的健康个体67例为健康组。酶联免疫吸附试验检测血清PGRN水平。采用疼痛视觉模拟评分（VAS）和Harris评分评价髋关节疼痛及功能情况，比较不同临床特征NONFH患者的血清PGRN水平；对PGRN与临床指标进行相关性分析；采用受试者工作特征（ROC）曲线分析血清PGRN水平对NONFH的诊断价值。结果 NONFH组血清PGRN水平高于健康组（P<0.05）。不同病因NONFH患者组间PGRN水平比较差异无统计学意义；双侧坏死的NONFH患者PGRN水平显著高于单侧坏死患者，股骨头塌陷NONFH患者PGRN水平显著高于未塌陷患者（P<0.05）；血清PGRN水平与股骨头坏死国际骨循坏协会（ARCO）分期（r_s=0.645）、疼痛VAS评分呈正相关（r=0.694），与Harris评分呈负相关（r=-0.732，均P<0.01）。ROC曲线结果显示PGRN用于诊断NONFH的曲线下面积为0.786（95%CI：0.710~0.862，P<0.01），最佳临界值为14.55 μg/L，敏感度为0.640，特异度为0.910。结论血清PGRN水平可反映NONFH的病情严重程度，对NONFH的诊断存在一定价值。

关键词: 股骨头坏死, 生物标记, 颗粒蛋白前体, 股骨头塌陷

Abstract:

Objective To explore the clinical value of serum progranulin (PGRN) in non-traumatic osteonecrosis of femoral head (NONFH). Methods A total of 75 patients with NONFH were selected as the NONFH group, and 67 healthy individuals matched for sex and age were selected as the healthy group. Serum PGRN concentration was detected by enzyme-linked immunosorbent assay. The visual analogue scale (VAS) and Harris score were used to evaluate the hip joint pain and function. The general data and imaging results were compared between the two groups. The serum PGRN levels of NONFH patients with different clinical characteristics were compared. The correlation between PGRN and clinical indicators was analyzed. Receiver operating characteristic (ROC) curve was used to analyze the diagnostic value of serum PGRN level in NONFH. Results The level of serum PGRN was significantly higher in the NONFH group than that in the healthy group (P<0.05). There was no significant difference in PGRN levels between NONFH patients with different etiologies. The level of PGRN was significantly higher in NONFH patients with bilateral necrosis than that in patients with unilateral necrosis, and the level of PGRN was significantly higher in NONFH patients with femoral head collapse than that in patients without collapse (P<0.05). The level of serum PGRN was positively correlated with ARCO stage (r_s=0.645) and VAS score of pain (r=0.694), but negatively correlated with Harris score (r=-0.732, P<0.01). ROC curve results showed that the area under the curve of PGRN for the diagnosis of NONFH was 0.786 (95%CI: 0.710-0.862, P<0.01), the optimal cut-off value was 14.55 μg/L, the sensitivity was 0.640 and the specificity was 0.910. Conclusion Serum PGRN level can reflect the severity of NONFH and has certain value in the diagnosis of NONFH.

Key words: femur head necrosis, biomarkers, progranulin, collapse of the femoral head

中图分类号:

R681.8

图/表 2

参考文献 20

[1]	ZHAO D, ZHANG F, WANG B, et al. Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults(2019 version)[J]. J Orthop Translat, 2020, 21:100-110. doi:10.1016/j.jot.2019.12.004.
[2]	GUGGENBUHL P, ROBIN F, CADIOU S, et al. Etiology of avascular osteonecrosis of the femoral head[J]. Morphologie, 2021, 105(349):80-84. doi:10.1016/j.morpho.2020.12.002.
[3]	温家福, 韦标方. 激素性股骨头坏死骨髓间充质干细胞成骨分化的研究进展[J]. 解放军医学杂志, 2020, 45(11):1207-1214.
	WEN J F, WEI B F. Research progress in osteogenic differentiation of bone marrow mesenchymal stem cells in steroid-induced osteonecrosis of the femoral head[J]. Med J Chin PLA, 2020, 45(11):1207-1214. doi:10.11855/j.issn.0577-7402.2020.11.16.
[4]	HINES J T, JO W L, CUI Q, et al. Osteonecrosis of the femoral head: an updated review of ARCO on pathogenesis,staging and treatment[J]. J Korean Med Sci, 2021, 36(24):e177. doi:10.3346/jkms.2021.36.e177.
[5]	LIU M, ZHAO G, WEI B F. Attenuated serum vasoactive intestinal peptide concentrations are correlated with disease severity of non-traumatic osteonecrosis of femoral head[J]. J Orthop Surg Res, 2021, 16(1):325. doi:10.1186/s13018-021-02486-3.
[6]	JIAN J, LI G, HETTINGHOUSE A, et al. Progranulin:A key player in autoimmune diseases[J]. Cytokine, 2018, 101:48-55. doi:10.1016/j.cyto.2016.08.007.
[7]	李春江, 齐斌. 颗粒蛋白前体与类风湿性关节炎的关系[J]. 中华实用诊断与治疗杂志, 2015, 29(5):471-472,475.
	LI C J, Qi B. Relationship between progranulin and rheumatoid arthritis[J]. Journal of Chinese Practical Diagnosis and Therapy, 2015, 29(5):471-472,475. doi:10.13507/j.issn.1674-3474.2015.05.020.
[8]	KONOPKA J, RICHBOURGH B, LIU C. The role of PGRN in musculoskeletal development and disease[J]. Front Biosci(Landmark Ed), 2014, 19(4):662-671. doi:10.2741/4234.
[9]	POGONOWSKA M, PONIATOWSKI Ł A, WAWRZYNIAK A, et al. The role of progranulin(PGRN)in the modulation of anti-inflammatory response in asthma[J]. Cent Eur J Immunol, 2019, 44(1):97-101. doi:10.5114/ceji.2019.83267.
[10]	YUE Y B, LIU X, WEI B F. Attenuated serum adiponectin levels are associated with disease severity in patients with non-traumatic osteonecrosis of the femoral head[J]. J Pain Res, 2017, 10:2387-2393. doi:10.2147/JPR.S143036.
[11]	林清宇, 韦标方. 血清纤维蛋白原α链在非创伤性股骨头坏死中的意义[J]. 中国矫形外科杂志, 2020, 28(23):2131-2134.
	LIN Q Y, WEI B F. Significance of serum fibrinogen alpha chain levels in non-traumatic osteonecrosis of the femoral head[J]. Orthopedic Journal of China, 2020, 28(23):2131-2134. doi:10.3977/j.issn.1005-8478.2020.23.05.
[12]	TOH H, CHITRAMUTHU B P, BENNETT H P, et al. Structure,function,and mechanism of progranulin; the brain and beyond[J]. J Mol Neurosci, 2011, 45(3):538-548. doi:10.1007/s12031-011-9569-4.
[13]	JIAN J, KONOPKA J, LIU C. Insights into the role of progranulin in immunity, infection, and inflammation[J]. J Leukoc Biol, 2013, 93(2):199-208. doi:10.1189/jlb.0812429.
[14]	WEI J, HETTINGHOUSE A, LIU C. The role of progranulin in arthritis[J]. Ann N Y Acad Sci, 2016, 1383(1):5-20. doi:10.1111/nyas.13191.
[15]	ZHAO Y P, TIAN Q Y, LIU B, et al. Progranulin knockout accelerates intervertebral disc degeneration in aging mice[J]. Sci Rep, 2015, 5:9102. doi:10.1038/srep09102.
[16]	HAN Y, SI M, ZHAO Y, et al. Progranulin protects against osteonecrosis of the femoral head by activating ERK1/2 pathway[J]. Inflammation, 2017, 40(3):946-955. doi:10.1007/s10753-017-0539-z.
[17]	JIN Y, ZHU H X, WEI B F. Reduced serum and local LncRNA MALAT1 expressions are linked with disease severity in patients with non-traumatic osteonecrosis of the femoral head[J]. Technol Health Care, 2021, 29(3):479-488. doi:10.3233/THC-202244.
[18]	WANG C, SUN W, LING S, et al. AAV-Anti-miR-214 prevents collapse of the femoral head in osteonecrosis by regulating osteoblast and osteoclast activities[J]. Mol Ther Nucleic Acids, 2019, 18:841-850. doi:10.1016/j.omtn.2019.09.030.
[19]	DING Y, WEI J, HETTINGHOUSE A, et al. Progranulin promotes bone fracture healing via TNFR pathways in mice with type 2 diabetes mellitus[J]. Ann N Y Acad Sci, 2021, 1490(1):77-89. doi:10.1111/nyas.14568.
[20]	CHEN J, YU M, LI X, et al. Progranulin promotes osteogenic differentiation of human periodontal ligament stem cells via tumor necrosis factor receptors to inhibit TNF-α sensitized NF-kB and activate ERK/JNK signaling[J]. J Periodontal Res, 2020, 55(3):363-373. doi:10.1111/jre.12720.

组别	n	性别（男/女）	年龄（岁）	BMI （kg/m²）	PGRN （μg/L）
健康组	67	46/21	42.52±10.20	23.83±3.09	9.99±3.59
NONFH组	75	54/21	42.96±9.97	24.00±3.09	18.94±10.30
χ²或t		0.190	0.258	0.322	6.750^＊＊

组别	n	性别（男/女）	年龄（岁）	BMI （kg/m²）	PGRN （μg/L）
健康组	67	46/21	42.52±10.20	23.83±3.09	9.99±3.59
NONFH组	75	54/21	42.96±9.97	24.00±3.09	18.94±10.30
χ²或t		0.190	0.258	0.322	6.750^＊＊

非创伤性股骨头坏死患者血清颗粒蛋白前体表达及临床意义

Clinical significance of serum expression of progranulin in non-traumatic osteonecrosis of femoral head

引用本文

RichHTML

PDF (PC)

可视化

摘要/Abstract

使用本文

图/表 2

参考文献 20

相关文章 10

编辑推荐

Metrics

本文评价

[1]	马佳佳, 张亚苹, 杨斌, 赵美琪, 蒋璐, 黄小玉, 范路畅, 王凤梅. ATOX1通过JAK2/STAT3通路促进肝癌细胞生物学行为的机制探讨[J]. 天津医药, 2024, 52(9): 907-912.
[2]	钱士达, 于雪峰. 骨髓间充质干细胞治疗激素性股骨头坏死的研究进展[J]. 天津医药, 2023, 51(5): 553-555.
[3]	胡加海, 薛松, 陈荃. 卡瑞利珠单抗联合化疗方案对中晚期食管癌患者血清miR-21、可溶性E-钙黏蛋白表达的影响[J]. 天津医药, 2022, 50(8): 873-877.
[4]	许家威, 郭一慧, 宋辉, 程纬民. Wnt/β-catenin信号通路在多发性骨髓瘤中的机制研究进展[J]. 天津医药, 2022, 50(8): 888-891.
[5]	卢洁, 张芯, 王涛, 杨宁. 环状RNA对房颤患者的影响及其作用机制研究[J]. 天津医药, 2022, 50(3): 333-336.
[6]	金炼驰, 赖永洁△. 软骨寡聚基质蛋白与疾病关系的研究进展[J]. 天津医药, 2021, 49(3): 330-336.
[7]	李丽, 宋茜, 刘冉录. 前列腺癌诊断标志物检测研究进展[J]. 天津医药, 2019, 47(8): 880-884.
[8]	张颖, 张蕾蕾, 马向浩, 陈献韬, 王会超, 刘又文. 3D 打印钛合金骨小梁重建棒治疗早期股骨头坏死的有效性分析#br#[J]. 天津医药, 2017, 45(11): 1222-1227.
[9]	华静娜，孙昕，吴琦，李莉，邢志珩，赵新骞. 严重急性呼吸综合征患者十年生存质量分析[J]. 天津医药, 2016, 44(10): 1247-1250.
[10]	石正松，李强，蔡伟良，宁寅宽，李诗鹏. 腺病毒介导hBMP-2转染BMSCs复合DBM修复兔缺血性股骨头坏死的实验研究[J]. 天津医药, 2015, 43(10): 1128-1132.